The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
Abstract
MicroRNAs have been implicated in regulating diverse cellular pathways. Although there is emerging evidence that some microRNAs can function as oncogenes or tumour suppressors, the role of microRNAs in mediating cancer metastasis remains unexplored. Here we show, using a combination of mouse and human cells, that microRNA-10b (miR-10b) is highly expressed in metastatic breast cancer cells and positively regulates cell migration and invasion. Overexpression of miR-10b in otherwise non-metastatic breast tumours initiates robust invasion and metastasis. Expression of miR-10b is induced by the transcription factor Twist, which binds directly to the putative promoter of mir-10b (MIRN10B). The miR-10b induced by Twist proceeds to inhibit translation of the messenger RNA encoding homeobox D10, resulting in increased expression of a well-characterized pro-metastatic gene, RHOC. Significantly, the level of miR-10b expression in primary breast carcinomas correlates with clinical progression. These findings suggest the workings of an undescribed regulatory pathway, in which a pleiotropic transcription factor induces expression of a specific microRNA, which suppresses its direct target and in turn activates another pro-metastatic gene, leading to tumour cell invasion and metastasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This expression pattern is different from those of the other cancer-associated miRNAs, for example, miR-10b, which is often elevated in grade III and even grade II gliomas (Fig. 1) and dysregulated in some other cancers (41).”
From MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators (2008) · cites this paper as [41]
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
MicroRNA expression profiles classify human cancers
Lü, J., Getz, G. A., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,637
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1997 · Cited by 7,668
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature reviews. Cancer · doi:10.1038/nrc822 · Cited by 6,767
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Prediction of Mammalian MicroRNA Targets
Lewis, B. P., Shih, I.-H., Jones-Rhoades, M. W., Bartel, D. P., & Burge, C. B. (2003) · Cell · doi:10.1016/s0092-8674(03)01018-3 · Cited by 5,199
The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686
Combinatorial microRNA target predictions
Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,096
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
Flagged first, then by citations
1 of the 49 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 901–1,000 of 1,004
Xu, M., & Mo, Y. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1129-8 · Cited by 65
MicroRNA theragnostics for the clinical management of multiple myeloma
Ahmad, N., Haider, S. A., Jagannathan, S., Anaissie, E. J., & Driscoll, J. J. (2013) · Leukemia · doi:10.1038/leu.2013.262 · Cited by 64
MicroRNAs and human diseases: diagnostic and therapeutic potential
Maqbool, R., & Hussain, M. U. (2014) · Cell and Tissue Research · doi:10.1007/s00441-013-1787-3 · Cited by 66
A study of miRNAs targets prediction and experimental validation
Huang, Y., Zou, Q., Song, H., Song, F., Wang, L., Zhang, G., & Shen, X. (2010) · Protein & Cell · doi:10.1007/s13238-010-0129-4 · Cited by 66
MicroRNAs: Potential biomarkers in cancer
George, G. P., & Mittal, R. D. (2010) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-010-0008-z · Cited by 65
Silencing of the IKKε gene by siRNA inhibits invasiveness and growth of breast cancer cells
Qin, B. Y., & Cheng, K. (2010) · Breast Cancer Research · doi:10.1186/bcr2644 · Cited by 64
Xu, X., Zhang, Y., Jasper, J. S., Lykken, E. A., Alexander, P. B., Markowitz, G. J., McDonnell, D. P., Li, Q.-J., & Wang, X.-F. (2016) · Oncotarget · doi:10.18632/oncotarget.7953 · Cited by 66
Lo, P., Zhang, Y., Yao, Y., Wolfson, B., Yu, J. E., Han, S., Duru, N., & Zhou, Q. Y. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.775080 · Cited by 63
Small molecules with big roles in microRNA chemical biology and microRNA-targeted therapeutics
Fan, R., Xiao, C., Wan, X., Cha, W., Miao, Y., Zhou, Y., Qin, C., Cui, T., Su, F., & Shan, X. (2019) · RNA Biology · doi:10.1080/15476286.2019.1593094 · Cited by 65
MicroRNAs as Molecular Targets for Cancer Therapy: On the Modulation of MicroRNA Expression
Costa, P. M., & de Lima, M. C. P. (2013) · Pharmaceuticals · doi:10.3390/ph6101195 · Cited by 63
Li, Y., Zhang, Y., Li, S., Lu, J., Chen, J., Wang, Y., Li, Y., Xu, J., & Li, X. (2015) · Scientific Reports · doi:10.1038/srep08790 · Cited by 64
Mukhopadhyay, P., Lakshmanan, I., Ponnusamy, M. P., Chakraborty, S., Jain, M., Pai, P., Smith, L. M., Lele, S. M., & Batra, S. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054455 · Cited by 63
Chen, W., Tang, Z., Sun, Y., Zhang, Y., Wang, X., Shen, Z., Liu, F., & Qin, X. (2011) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2011.411 · Cited by 63
The Role of MicroRNAs in the Control of Innate Immune Response in Cancer
Jasinski‐Bergner, S., Mandelboim, O., & Seliger, B. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju257 · Cited by 66
Jikuzono, T., Kawamoto, M., YOSHITAKE, H., KIKUCHI, K., Akasu, H., Ishikawa, H., Hirokawa, M., Miyauchi, A., Tsuchiya, S., Shimizu, K., et al. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1879 · Cited by 63
MicroRNAs: Promising New Antiangiogenic Targets in Cancer
Gallach, S., Fariñas, S. C., Lewintre, E. J., & Camps, C. (2014) · BioMed Research International · doi:10.1155/2014/878450 · Cited by 64
Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma
Lu, C.-Y., Chen, S.-Y., Peng, H.-L., Kan, P., Chang, W., & Yen, C.-J. (2016) · Oncotarget · doi:10.18632/oncotarget.14115 · Cited by 63
Exosomal microRNA: a Novel Biomarker for Breast Cancer
He, Y., Deng, F., Yang, S., Wang, D., Chen, X., Zhong, S., Zhao, J., & Tang, J. (2017) · Biomarkers in Medicine · doi:10.2217/bmm-2017-0305 · Cited by 64
Deregulated miRNAs in osteoporosis: effects in bone metastasis
Bellavia, D., Salamanna, F., Raimondi, L., Luca, A. D., Carina, V., Costa, V., Alessandro, R., Fini, M., & Giavaresi, G. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03162-w · Cited by 63
Epigenetics of Breast Cancer: Clinical Status of Epi-drugs and Phytochemicals
Shukla, S., Penta, D., Mondal, P., & Meeran, S. M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-20301-6_16 · Cited by 65
Huang, J., Sun, C., Wang, S., He, Q., & Li, D. (2015) · Molecular BioSystems · doi:10.1039/c4mb00752b · Cited by 62
The Emerging Role of MicroRNAs in Breast Cancer
Yang, Z., & Liu, Z. (2020) · Journal of Oncology · doi:10.1155/2020/9160905 · Cited by 66
Liu, Y., Sukumar, U. K., Kanada, M., Krishnan, A., Massoud, T. F., & Paulmurugan, R. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202103600 · Cited by 62
The roles of microRNAs in the regulation of tumor metastasis
Zhou, L., Liu, F., Wang, X., & Ouyang, G. (2015) · Cell & Bioscience · doi:10.1186/s13578-015-0028-8 · Cited by 63
Epigenetic Silencing of ITGA2 by MiR-373 Promotes Cell Migration in Breast Cancer
Ding, W. J., Fan, X., Xu, X., Huang, J., Xu, S., Geng, Q., Li, R., Chen, D., & Yan, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135128 · Cited by 62
5-fluorouracil drug alters the microrna expression profiles in MCF-7 breast cancer cells
Shah, M., Pan, X., Fix, L. N., Farwell, M. A., & Zhang, B. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22517 · Cited by 63
MicroRNA-495 induces breast cancer cell migration by targeting JAM-A
Cao, M., Nie, W., Li, J., Zhang, Y., Yan, X., Guan, X., Chen, X., Zen, K., Zhang, C., Jiang, X., et al. (2014) · Protein & Cell · doi:10.1007/s13238-014-0088-2 · Cited by 64
MiR-335 inhibits migration of breast cancer cells through targeting oncoprotein c-Met
Gao, Y., Zeng, F., Wu, J., Li, H., Fan, J., Mai, L., Zhang, J., Ma, D., Li, Y., & Song, F. (2014) · Tumor Biology · doi:10.1007/s13277-014-2917-6 · Cited by 62
Genomic and Epigenomic Cross-talks in the Regulatory Landscape of miRNAs in Breast Cancer
Samantarrai, D., Dash, S., Chhetri, B., & Mallick, B. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0649 · Cited by 65
MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype
Santarpia, L., Nicoloso, M. S., & Calin, G. A. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0222 · Cited by 63
Lim, W., Kim, H., Kim, Y., Choi, K., Lee, I.-H., Lee, K. H., Kim, M. K., & Ko, H. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.06.014 · Cited by 62
Tripathi, K., & Garg, M. (2018) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-017-0441-3 · Cited by 62
Dutta, A., Goswami, U., & Chattopadhyay, A. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b05160 · Cited by 62
Ell, B. J., Qiu, Q., Wei, Y., Mercatali, L., Ibrahim, T., Amadori, D., & Kang, Y. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.582866 · Cited by 61
Spinelli, C., Adnani, L., Choi, D., & Rak, J. W. (2018) · Non-Coding RNA · doi:10.3390/ncrna5010001 · Cited by 66
MicroRNA and ER stress in cancer
Kim, T., & Croce, C. M. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.12.025 · Cited by 63
The impact of microRNAs and alternative splicing in pharmacogenomics
Passetti, F., Ferreira, C. G., & Costa, F. F. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2008.14 · Cited by 60
The Janus‐faced role of ezrin in “linking” cells to either normal or metastatic phenotype
Brambilla, D., & Fais, S. (2009) · International Journal of Cancer · doi:10.1002/ijc.24734 · Cited by 61
MicroRNAs in colorectal cancer: Function, dysregulation and potential as novel biomarkers
Nugent, M., Miller, N., & Kerin, M. J. (2011) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2011.05.005 · Cited by 61
Clinicopathologic significance of miR-10b expression in gastric carcinoma
Wang, Y., Ye, Z., Zhao, Z., Li, L., Wang, Y., Tao, H., Wang, H., & He, X. (2013) · Human Pathology · doi:10.1016/j.humpath.2012.10.014 · Cited by 61
Shi, Y., Peng, Y., & Long, X. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485344 · Cited by 61
Strategies to Target Matrix Metalloproteinases as Therapeutic Approach in Cancer
Piperigkou, Z., Manou, D., Καραμάνου, Κ., & Theocharis, A. D. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7595-2_27 · Cited by 62
Novel Molecular Markers for Breast Cancer
Inoue, K., & Fry, E. A. (2016) · Biomarkers in Cancer · doi:10.4137/bic.s38394 · Cited by 64
Nugent, M. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-23730-5_11 · Cited by 60
Yu, S., Liang, C., Xiao, Q., Li, G., Ding, P., & Luo, J. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14048 · Cited by 60
Sarver, A. L., Sarver, A. E., Yuan, C., & Subramanian, S. (2018) · BMC Cancer · doi:10.1186/s12885-018-5085-z · Cited by 60
Aggarwal, V., Priyanka, K., & Tuli, H. S. (2020) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-020-00447-w · Cited by 61
MicroRNA-21 is immunosuppressive and pro-metastatic via separate mechanisms
Chi, L. H., Cross, R. S., Redvers, R. P., Davis, M. J., Hediyeh-zadeh, S., Mathivanan, S., Samuel, M., Lucas, E. C., Mouchemore, K. A., Gregory, P. A., et al. (2022) · Oncogenesis · doi:10.1038/s41389-022-00413-7 · Cited by 68
Effect of microRNA-206 on Cytoskeleton Remodelling by Downregulating Cdc42 in MDA-MB-231 Cells
Liu, H., Cao, Y., Ye, W., & Sun, Y. (2010) · Tumori Journal · doi:10.1177/030089161009600518 · Cited by 60
Stadthagen, G., Tehler, D., Høyland‐Kroghsbo, N. M., Wen, J., Krogh, A., Jensen, K. T., Santoni‐Rugiu, E., Engelholm, L. H., & Lund, A. H. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003913 · Cited by 61
Takahashi, M., Miyazaki, H., Furihata, M., Sakai, H., Konakahara, T., Watanabe, M., & Okada, T. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-009-9281-8 · Cited by 60
miRNAs can predict prostate cancer biochemical relapse and are involved in tumor progression
Jung, K. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1128 · Cited by 60
miRNAs in breast cancer tumorigenesis (Review)
ZHANG, Z. J., & Shi, L. (2011) · Oncology Reports · doi:10.3892/or.2011.1611 · Cited by 64
Wu, Z., Sun, L., Wang, H., Yao, J.-S., Jiang, C., Xu, W., & Yang, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047270 · Cited by 60
Ge, Y., Zhang, L., Nikolova, M., Reva, B. A., & Fuchs, E. V. (2015) · Nature Cell Biology · doi:10.1038/ncb3275 · Cited by 63
Patel, N., Garikapati, K. R., Ramaiah, M. J., Polavarapu, K. K. B., Bhadra, U., & Bhadra, M. P. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.08.028 · Cited by 61
Identification of breast cancer mechanism based on weighted gene coexpression network analysis
Guo, X., Xiao, H., Guo, S., Dong, L., & Chen, J. (2017) · Cancer Gene Therapy · doi:10.1038/cgt.2017.23 · Cited by 60
RhoC: a fascinating journey from a cytoskeletal organizer to a Cancer stem cell therapeutic target
Thomas, P., Pranatharthi, A., Ross, C. R., & Srivastava, S. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1327-4 · Cited by 60
Yue, R., Chen, M., & Ma, N. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c09494 · Cited by 61
Findlay, V. J., Turner, D. P., Moussa, O., & Watson, D. K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0907 · Cited by 60
The emerging molecular machinery and therapeutic targets of metastasis
Sun, Y., & Ma, L. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.001 · Cited by 61
Self-citationSong, M., Park, Y., & Ryu, J. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.08.016 · Cited by 62
Shevde, L. A., Metge, B. J., Mitra, A., Xi, Y., Ju, J., KING, J. A. C., & Samant, R. S. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00821.x · Cited by 60
Circulating MicroRNAs as Biomarkers in Hepatocellular Carcinoma Screening
Jiang, L., Cheng, Q., Zhang, B., & Zhang, M. (2015) · Medicine · doi:10.1097/md.0000000000000603 · Cited by 59
Current molecular diagnostics of breast cancer and the potential incorporation of microRNA
Zoon, C. K., Starker, E. Q., Wilson, A. M., Emmert‐Buck, M. R., Libutti, S. K., & Tangrea, M. A. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.25 · Cited by 59
Zhong, X., Coukos, G., & Zhang, L. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-427-8_21 · Cited by 60
Qiu, Y., Liu, Y., Li, W.-H., Zhang, H., Tian, X., & Fang, W. (2017) · Oncology Reports · doi:10.3892/or.2017.6081 · Cited by 58
Bourguignon, L. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00492 · Cited by 58
Advances of Epigenetic Biomarkers and Epigenome Editing for Early Diagnosis in Breast Cancer
Sarvari, P., Sarvari, P., Ramírez‐Díaz, I., Mahjoubi, F., & Rubio, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179521 · Cited by 68
A Narrative Review on CD44’s Role in Glioblastoma Invasion, Proliferation, and Tumor Recurrence
Inoue, A., Ohnishi, T., Nishikawa, M., Ohtsuka, Y., Kusakabe, K., Yano, H., Tanaka, J., & Kunieda, T. (2023) · Cancers · doi:10.3390/cancers15194898 · Cited by 59
Li, S., Kendall, S. E., Raices, R. M., Finlay, J. B., Covarrubias, M., Liu, Z., Lowe, G. N., Lin, Y.-H., Teh, Y. H., Leigh, V., et al. (2012) · BMC Biology · doi:10.1186/1741-7007-10-73 · Cited by 58
Shielding the messenger (RNA): microRNA-based anticancer therapies
Sotillo, E., & Thomas‐Tikhonenko, A. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.04.006 · Cited by 59
MicroRNAs in cancer management and their modulation by dietary agents
Karius, T., Schnekenburger, M., Dicato, M. A., & Diederich, M. F. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.02.004 · Cited by 61
TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation
Drasin, D. J., Guarnieri, A. L., Neelakantan, D., Kim, J., Cabrera, J. H., Wang, C.-A., Zaberezhnyy, V., Gasparini, P., Cascione, L., Huebner, K., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2394 · Cited by 58
microRNAs and EMT in Mammary Cells and Breast Cancer
Wright, J. A., Richer, J. K., & Goodall, G. J. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9183-z · Cited by 59
Yuen, H., Kwok, W. T., Chan, K.-K., Chua, C.-W., Chan, Y.-P., Chu, Y.-Y., Wong, Y.-C., Wang, X., & Chan, K. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn105 · Cited by 58
Twist Is Required for Thrombin-Induced Tumor Angiogenesis and Growth
Hu, L., Roth, J., Brooks, P. C., Ibrahim, S., & Karpatkin, S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0067 · Cited by 58
miR-27b inhibits gastric cancer metastasis by targeting NR2F2
Feng, Q., Wu, X., Li, F., Ning, B., Lu, X., Zhang, Y., Pan, Y., & Guan, W. (2016) · Protein & Cell · doi:10.1007/s13238-016-0340-z · Cited by 58
MicroRNA-10b indicates a poor prognosis of non-small cell lung cancer and targets E-cadherin
Zhang, J., Xu, L., Yang, Z., Lu, H., Da-wei, H., Li, W., Zhang, Z., Liu, B., & Ma, S. (2014) · Clinical & Translational Oncology · doi:10.1007/s12094-014-1213-7 · Cited by 57
MicroRNA-10b overexpression promotes non-small cell lung cancer cell proliferation and invasion
Liu, Y., Li, M., Zhang, G., & Pang, Z. (2013) · European journal of medical research · doi:10.1186/2047-783x-18-41 · Cited by 58
MicroRNA-542-3p Suppresses Tumor Cell Invasion via Targeting AKT Pathway in Human Astrocytoma
Cai, J., Zhao, J., Zhang, N., Xu, X., Li, R., Yang, Y., Fang, L., Zhang, L., Li, M., Wu, J., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.649004 · Cited by 56
The prognostic significance of RUNX2 and miR-10a/10b and their inter-relationship in breast cancer
Chang, C., Fan, T.-C., Yu, J., Liao, G., Lin, Y.-C., Shih, A. C.-C., Li, W., & Yu, A. L.-T. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0257-3 · Cited by 57
Zhang, P. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i34.12241 · Cited by 58
Two-dimensional combinatorial screening enables the bottom-up design of a microRNA-10b inhibitor
Velagapudi, S. P., & Disney, M. D. (2014) · Chemical Communications · doi:10.1039/c3cc00173c · Cited by 57
Taoka, M., Yamauchi, Y., Nobe, Y., Masaki, S., Nakayama, H., Ishikawa, H., Takahashi, N., & Isobe, T. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp732 · Cited by 57
MiR-378 Promotes the Migration of Liver Cancer Cells by Down-Regulating Fus Expression
Ma, J., Lin, J., Qian, J., Wei, Q., Yin, J., Yang, B. B., Tang, Q., Chen, X., Wen, X., Guo, H., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000369669 · Cited by 57
Liu, M., Zhou, K., & Cao, Y. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-245 · Cited by 57
Lee, G.-A., Hwang, K., & Choi, K. (2016) · Toxins · doi:10.3390/toxins8060162 · Cited by 58
Epigenetic effects of carbon nanotubes in human monocytic cells
Öner, D., Moisse, M., Ghosh, M., Duca, R. C., Poels, K. L. C., Luyts, K., Putzeys, E., Čokić, S. M., LANDUYT, K. L. V., Vanoirbeek, J. A., et al. (2016) · Mutagenesis · doi:10.1093/mutage/gew053 · Cited by 57
Zhao, K., Zhang, Y., Kang, L., Song, Y., Wang, K., Li, S., Wu, X., Hua, W., Shao, Z., Yang, S., et al. (2017) · Gene · doi:10.1016/j.gene.2017.07.043 · Cited by 57
Weidle, U. H., Dickopf, S., Hintermair, C., Kollmorgen, G., Birzele, F., & Brinkmann, U. (2018) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20062 · Cited by 57
Catalytic hairpin assembly gel assay for multiple and sensitive microRNA detection
Dai, W., Zhang, J., Meng, X., He, J., Zhang, K., Cao, Y., Wang, D., Dong, H., & Zhang, X. (2018) · Theranostics · doi:10.7150/thno.24480 · Cited by 57
Tao, L., Wu, Y., & Zhang, S. (2019) · Neoplasma · doi:10.4149/neo_2018_181207n930 · Cited by 58
Chen, J., Deng, Y., Ao, L., Song, Y., Xu, Y., Wang, C. C., Choy, K. W., Chung, K. H. T., Du, Q., Sui, Y., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.06.015 · Cited by 57
Kashyap, D., & Kaur, H. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117417 · Cited by 57
MicroRNA 203 Modulates Glioma Cell Migration via Robo1/ERK/MMP-9 Signaling
Dontula, R., Dinasarapu, A. R., Chetty, C., Pannuru, P., Herbert, E., Ozer, H., & Lakka, S. S. (2013) · Genes & Cancer · doi:10.1177/1947601913500141 · Cited by 56
Regulation of Metastasis by microRNAs in Ovarian Cancer
Wang, Y., Kim, S., & Kim, I. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00143 · Cited by 56
MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine
Smith, B., Agarwal, P., & Bhowmick, N. A. (2017) · Endocrine Related Cancer · doi:10.1530/erc-16-0525 · Cited by 56
Signaling pathways and mesenchymal transition in pediatric high-grade glioma
Meel, M. H., Schaper, S. A., Kaspers, G. J. L., & Hulleman, E. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2714-7 · Cited by 58
MiRNA-related metastasis in oral cancer: moving and shaking
Eslami, M., Khazeni, S., Khanaghah, X. M., Asadi, M. H., Ansari, M. A., Garjan, J. H., Lotfalizadeh, M. H., Bayat, M., Taghizadieh, M., Taghavi, S. P., et al. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03022-5 · Cited by 59
Metadata
- Authors
- Ma, L., Teruya-Feldstein, J., & Weinberg, R. A.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Corresponding author
- Weinberg, Robert A.
- Venue
- Nature
- Published
- 2007-09-26
- Volume
- 449
- Issue
- 7163
- Pages
- 682-688
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2047529648
- Cited by
- 2,605
- References
- 49
- Citations by year
- 2026: 34 · 2025: 36 · 2024: 66 · 2023: 69 · 2022: 75 · 2021: 120 · 2020: 106 · 2019: 123 · 2018: 113 · 2017: 151 · 2016: 160 · 2015: 196 · 2014: 215 · 2013: 226 · 2012: 220
- FWCI
- 60.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- microRNA-10b, breast cancer, metastasis, tumor invasion, cell migration, Twist transcription factor, HOXD10, RhoC, Hox genes, microRNA target regulation, clinical progression
- MeSH terms
- rhoC GTP-Binding Protein, Animals, Base Sequence, Breast Neoplasms, Cell Movement, Humans, Lung Neoplasms, Neoplasm Invasiveness, Neoplasm Metastasis, Peritoneal Neoplasms, Transcription Factors, Gene Expression Regulation, Neoplastic, Homeodomain Proteins, rho GTP-Binding Proteins, MicroRNAs, Cell Line, Tumor, Mice, Twist-Related Protein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review